Skip to content

Drug interactions

Isocarboxazid + Metformin-sitagliptin

Severity: Moderate

Isocarboxazid and Metformin-sitagliptin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

MAO inhibitors can enhance the glucose-lowering effect of antidiabetic drugs and have been associated with hypoglycemia. The effect is more pronounced with insulin and sulfonylureas than with metformin or sitagliptin.

What this interaction means in plain words

Isocarboxazid and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Isocarboxazid belongs to Central Nervous System; Metformin-sitagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

MAO inhibition may increase insulin sensitivity and stimulate insulin secretion, adding to the glucose-lowering effect.

What to do

Monitor blood glucose when isocarboxazid is started or stopped and reduce antidiabetic doses if hypoglycemia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Isocarboxazid and Metformin-sitagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Isocarboxazid with Metformin-sitagliptin?

MediHelp rates the interaction as moderate. Isocarboxazid and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. MAO inhibitors can enhance the glucose-lowering effect of antidiabetic drugs and have been associated with hypoglycemia. The effect is more pronounced with insulin and sulfonylureas than with metformin or sitagliptin.

How serious is the interaction between Isocarboxazid and Metformin-sitagliptin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when isocarboxazid is started or stopped and reduce antidiabetic doses if hypoglycemia develops.

What other medicines interact with Metformin-sitagliptin?

MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in